Results 141 to 150 of about 12,091 (231)

Mutational landscape of classical myeloproliferative neoplasms in the Western Cape Province, South Africa. [PDF]

Afr J Lab Med
Dicks MJ, Nell EM, Swanepoel C, Abdullah I, Chapanduka ZC.   +4 more
europepmc   +1 more source

STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma. [PDF]

Oncoimmunology
Kepp O, Kroemer G.
europepmc   +1 more source

Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm. [PDF]

Am J Hematol
Rigolot L, Chea M, Largeaud L, Prade N, Dufrechou S, Condom P, Lhossein T, Juvin PY, Riol J, Frébet E, Migné H, Legoff I, Boivert C, Daniau B, Gueudet P, Bories P, Huguet F, Tavitian S, Delabesse E, De Mas V.   +19 more
europepmc   +1 more source

Ruolo della Calreticulina (CALR) nel differenziamento emopoietico e nello sviluppo di neoplasie mieloproliferative.

, 2016
Le neoplasie mieloproliferative BCR-ABL negative (MPNs), sono disordini clonali della cellula staminale caratterizzati da un’aumentata proliferazione delle cellule mieloidi terminalmente differenziate.
PRUDENTE, ZELIA
core  

CALR is differentially expressed in glioblastoma.

Glioblastoma is difficult to treat and patients are often provided poor prognosis (1), indicating a requirement for therapeutic target identification and drug development. Differentially expressed genes represent by definition among the most promising targets for the development of novel chemotherapies (2, 3).
openaire   +1 more source

Inflammatory and Immune Microenvironment in Myeloproliferative Neoplasms: Pathogenic Mechanisms and Therapeutic Opportunities. [PDF]

Cancers (Basel)
Kaikavoosnejad F, Keyhani A, Ashraf Moosavi SS, Verdi M, Yazdani MS, Dizaji Asl K, Mazloumi Z, Mirzaei H, Rafat A, Nejati R.   +9 more
europepmc   +1 more source

Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears. [PDF]

Ann Hematol
Eckardt JN, Reddy CBV, Hauspurg H, Riechert S, Schmittmann T, Srivastava I, Winter S, Sockel K, Badstübner M, Bornhäuser M, Tiemann M, Middeke JM.   +11 more
europepmc   +1 more source

Calr-mediated calcium buffering: a molecular barrier to in vivo cardiac reprogramming. [PDF]

Signal Transduct Target Ther
Kim J, Schöler HR, Kim KP.
europepmc   +1 more source

Allele burden expansion in <i>JAK2</i> ^V617F and <i>CALR</i>-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment. [PDF]

Hemasphere
Ng ZY, Cottin L, Demoy M, Paz DL, Orvain C, Lambert WC, Ianotto JC, Lippert E, Ross DM, Iarossi D, Khan A, Lock D, Truong C, Laribi K, Yang YF, Gagnon LL, Ugo V, Harrison CN, O'Sullivan J.   +18 more
europepmc   +1 more source

Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Shivarov V, Tsvetkova G, Micheva I, Hadjiev E, Petkova J, Madjarova G, Ivanova M.   +6 more
europepmc   +1 more source